scholarly journals Treatment plan quality assessment for radiotherapy of rectal cancer patients using prediction of organ-at-risk dose metrics

2020 ◽  
Vol 16 ◽  
pp. 74-80
Author(s):  
Ana Vaniqui ◽  
Richard Canters ◽  
Femke Vaassen ◽  
Colien Hazelaar ◽  
Indra Lubken ◽  
...  
2020 ◽  
Vol 152 ◽  
pp. S156-S157
Author(s):  
A. Vaniqui ◽  
R. Canters ◽  
F. Vaassen ◽  
C. Hazelaar ◽  
I. Lubken ◽  
...  

2021 ◽  
Vol 161 ◽  
pp. S348-S349
Author(s):  
V. Hernandez ◽  
C. Rønn Hansen ◽  
L. Widesott ◽  
N. Jornet

2010 ◽  
Vol 102 (3) ◽  
pp. 190-198 ◽  
Author(s):  
Maria Pisu ◽  
Lisa C. Richardson ◽  
Young-ll Kim ◽  
Helen Krontiras ◽  
Michelle Y. Martin ◽  
...  

2016 ◽  
Vol 58 (4) ◽  
pp. 579-590 ◽  
Author(s):  
Ghulam Murtaza ◽  
Stefania Cora ◽  
Ehsan Ullah Khan

Abstract Volumetric-modulated arc therapy (VMAT) is an efficient form of radiotherapy used to deliver intensity-modulated radiotherapy beams. The aim of this study was to investigate the relative insensitivity of VMAT plan quality to gantry angle spacing (GS). Most previous VMAT planning and dosimetric work for GS resolution has been conducted for single arc VMAT. In this work, a quantitative comparison of dose–volume indices (DIs) was made for partial-, single- and double-arc VMAT plans optimized at 2°, 3° and 4° GS, representing a large variation in deliverable multileaf collimator segments. VMAT plans of six prostate cancer and six head-and-neck cancer patients were simulated for an Elekta SynergyS® Linac (Elekta Ltd, Crawley, UK), using the SmartArc™ module of Pinnacle³ TPS, (version 9.2, Philips Healthcare). All optimization techniques generated clinically acceptable VMAT plans, except for the single-arc for the head-and-neck cancer patients. Plan quality was assessed by comparing the DIs for the planning target volume, organs at risk and normal tissue. A GS of 2°, with finest resolution and consequently highest intensity modulation, was considered to be the reference, and this was compared with GS 3° and 4°. The differences between the majority of reference DIs and compared DIs were <2%. The metrics, such as treatment plan optimization time and pretreatment (phantom) dosimetric calculation time, supported the use of a GS of 4°. The ArcCHECK™ phantom–measured dosimetric agreement verifications resulted in a >95.0% passing rate, using the criteria for γ (3%, 3 mm). In conclusion, a GS of 4° is an optimal choice for minimal usage of planning resources without compromise of plan quality.


Author(s):  
Iman Sherif Ahmed ◽  
Saher Mohamed El Gaafary ◽  
Remon Zaher Elia ◽  
Rasha S. Hussein

Abstract Background Treatment response varies significantly among rectal cancer patients. Tumor can show complete regression, stationary appearance, or even tumour progression during the treatment. It is also widely known that the rate of local recurrence is variable. Precise risk stratification of tumor aggressiveness is required for better per patient tailored treatment plan and predicting the overall prognosis of rectal cancer patients The aim of this study was to assess different parameters of baseline [18F] fluorodeoxyglucose positron emission tomography/computed tomography [(18F) FDG-PET/CT] as a non-invasive tool in predicting aggressiveness of the rectal cancer. Results Overall, 33 patients were included [19 moderately differentiated adenocarcinoma, 10 poorly differentiated adenocarcinoma and 4 mucinous adenocarcinomas (MAC)]. SUV estimates (SUV max, SUV mean) were greater in the moderately adenocarcinoma group (p = 0.003 and p = 0.019, respectively). MTV and TLG values were similar between the three histopathological groups (p = 0.763 and p = 0.701, respectively). There was no correlation between SUVmax of primary tumor and MTV (r = 0.034; p = 0.849). However, SUVmax and TLG were significantly correlated (r = 0.517; p = 0.002). Strong correlation between tumor size and MTV (r = 0.489; p = 0.003), and TLG (r = 0.506; p = 0.003) were observed. No significant association was found between MTV and TLG and the clinical stage of rectal cancer. Conclusion Baseline 18F-FDG PET/CT parameters cannot be used alone as a non-invasive diagnostic technique in assessing aggressiveness and prognosis in patients with primary rectal cancer, and further clinical studies are needed before considering the prognostic role of FDG-PET/CT in rectal cancer.


Author(s):  
Mitsuhiro Nakamura ◽  
Megumi Nakao ◽  
Nobutaka Mukumoto ◽  
Ryo Ashida ◽  
Hideaki Hirashima ◽  
...  

2021 ◽  
pp. 1-4
Author(s):  
H. S. Rønde ◽  
J. F. Kallehauge ◽  
C. J. S. Kronborg ◽  
L. Nyvang ◽  
B. L. Rekstad ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document